Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antiseptic Use and Dressing Application

This study has been completed.
Information provided by:
Maternite Regionale Universitaire Identifier:
First received: October 17, 2006
Last updated: September 18, 2009
Last verified: September 2009

The purposes of the study are:

  1. To compare the local efficacy (skin colonization) of 2 commercialized antiseptics used for the disinfection of the dressing application for an epicutaneocavous catheter (EPI).
  2. To evaluate whether the bacteria responsible for nosocomial infection is comparable to the flora diagnosed at the EPI site.

Condition Intervention Phase
Skin Colonization
Bacterial Infection
Procedure: disinfection efficacy using Biseptine
Procedure: disinfection efficacy using Amukin
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Comparison of Amukin Versus Biseptine Use for Dressing Application of Epicutaneocavous Catheters for Nosocomial Infection Prevention

Resource links provided by NLM:

Further study details as provided by Maternite Regionale Universitaire:

Primary Outcome Measures:
  • Efficacy on skin colonization of two commercially available antiseptics [ Time Frame: 2 weeks ]

Secondary Outcome Measures:
  • In case of nosocomial infection, relationship with skin bacteria [ Time Frame: 2 weeks ]

Enrollment: 453
Study Start Date: September 2006
Study Completion Date: October 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 2
Procedure: disinfection efficacy using Biseptine
Detersion and antiseptic application when changing catheter dressing
Other Name: Biseptine
Active Comparator: 1
Procedure: disinfection efficacy using Amukin
Detersion and antiseptic application when changing catheter dressing
Other Name: Amukin

Detailed Description:
Epicutaneocavous catheter is a significant risk factor for nosocomial infection in newborn infants. These infections have been related to local bacterial colonisation. Therefore thorough disinfection should lower the risk of nosocomial infection. However, the local efficacy of antiseptic use has not yet been clearly evaluated in this situation.

Ages Eligible for Study:   up to 3 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All infants admitted to the Neonatal Intensive Care Unit
  • Epicutaneocavous catheter insertion indication

Exclusion Criteria:

  • Epicutaneocavous catheter not inserted within the Unit
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00389558

Maternite Regionale Universitaire
Nancy, France, 54042
Sponsors and Collaborators
Maternite Regionale Universitaire
Study Director: Jean-Michel HASCOET, MD University of NANCY, France
Principal Investigator: Monique LUX, Pharmacist Maternite Regionale Universitaire
  More Information

Additional Information:
Responsible Party: Prof JM HASCOET, Maternite Regionale Universitaire Identifier: NCT00389558     History of Changes
Other Study ID Numbers: MRAP190406
Study First Received: October 17, 2006
Last Updated: September 18, 2009

Keywords provided by Maternite Regionale Universitaire:
Skin colonization
Epicutaneocavous catheter dressing

Additional relevant MeSH terms:
Bacterial Infections
Anti-Infective Agents, Local
Anti-Bacterial Agents
Anti-Infective Agents processed this record on May 24, 2017